Avenue Therapeutics Inc (ATXI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Operating Expenses | 2,863 | 914 | 872 | 951 | 1,001 |
| Operating Income | -2,863 | -914 | -872 | -951 | -1,001 |
| Other Income | 2 | 1 | 1 | 2 | 3 |
| Pre-tax Income | -2,861 | -913 | -871 | -949 | -998 |
| Net Income Continuous | -2,861 | -913 | -871 | -949 | -998 |
| Net Income | $-2,861 | $-913 | $-871 | $-949 | $-998 |
| EPS Basic Total Ops | -154.14 | -52.70 | -59.40 | -67.64 | -67.64 |
| EPS Basic Continuous Ops | -153.98 | -55.92 | -59.11 | -64.62 | -67.95 |
| EPS Diluted Total Ops | -154.14 | -52.70 | -59.40 | -67.64 | -67.64 |
| EPS Diluted Continuous Ops | -153.98 | -55.92 | -59.11 | -64.62 | -67.95 |
| EBITDA(a) | $-2,863 | $-914 | $-872 | $-951 | $-1,001 |